MODERN POSSIBILITIES FOR PREDICTING PREECLAMPSIA
https://doi.org/10.52485/19986173_2026_2_132
Abstract
Preeclampsia has long been a leading cause of maternal and infant morbidity and mortality worldwide, including in Russia. A history of preeclampsia, particularly in its severe forms, increases the risk of developing cardiovascular diseases, cerebrovascular complications, and peripartum cardiomyopathy, making prognosis and prevention crucial.
Over the past 20 years, a number of preeclampsia prognostic models have been proposed. Some are based solely on anamnestic risk factors and offer limited information. More modern models consider not only anamnestic risk but also various biometric indicators, such as uterine artery blood flow velocity, significantly increasing the informative value of the method and enabling dynamic prognostication.
This review presents current preeclampsia prognostic models used internationally and in the Russian Federation, along with data on their informative value.
About the Author
T. E. Kurmanbaev
Military Medical Academy named after S.M. Kirov
Russian Federation
Russian Federation
Timur Erlanovich Kurmanbaev, Candidate of Medical Sciences, Senior Lecturer at the Department of Obstetrics and Gynecology
6 Klinicheskaya, St. Petersburg, Russia, 194175
References
1. Rana S., Lemoine E., Granger J.P., Karumanchi S.A. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019.124(7).1094-1112. doi: 10.1161/CIRCRESAHA.118.313276.
2. Poon L. C., Shennan A., Hyett J. A., et al. The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int. J. Gynaecol. Obstet. 2019.145,(1). 1–33. doi:10.1002/ijgo.12802
3. Preeclampsia. Eclampsia. Edema, proteinuria, and hypertensive disorders during pregnancy, childbirth, and the postpartum period. Clinical guidelines. M.2024.79. In Russian
4. Panchuk YU. P., Yaroslavcev M. YU., Polonnikova A. A., i dr. Peripartum cardiomyopathy: a literature review and a clinical case report. Bulletin of the Reaviz Medical Institute: rehabilitation, doctor, and health. 2024.14(3).89-95. doi: 10.20340/vmi-rvz.2024.3.CASE.2. In Russian
5. Turbeville H. R., Sasser J. M. Preeclampsia beyond pregnancy: long-term consequences for mother and child. American Journal of Physiology-Renal Physiology.2020. 318(6). F1315-F1326. doi: 10.1152/ajprenal.00071.2020
6. Roberts J. M., Rich-Edwards J. W., McElrath T. F., et al. Subtypes of preeclampsia: recognition and determining clinical usefulness.Hypertension.2021.77(5).1430-1441. doi: 10.1161/HYPERTENSIONAHA.120.14781.
7. Erez O., Romero R., Jung E., Chaemsaithong P., Bosco M., Suksai M., et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022.226(2S).S786-S803. doi: 10.1016/j.ajog.2021.12.001.
8. Hu X., Jiang Y., Wang L., et al. Transcriptomics and metabolomics analysis reveal cell subpopulations of trophoblast cells associated with preeclampsia. Physiol Genomics. 2026.58(2). 89-100. doi: 10.1152/physiolgenomics.00185.2025.
9. Wiriyachoke N., Phaliwong P., Prommas S., Smanchat B., Bhamarapravatana K., Suwannarurk K. Prevalence and risk factors associated with severe features of pre-eclampsia among women in Thailand. BMC Pregnancy Childbirth. 2025.25(1).1311. doi: 10.1186/s12884-025-08499-8.
10. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol.2013.122(5). 1122-1131.
11. Chaemsaithong P., Pooh R.K., Zheng M.,et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gyn.2019.221(6).e1-650.e16. doi:10.1016/j.ajog.2019.09.041.
12. Poon, L., Kametas, N., Chelemen, T. et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 24, 104–110 (2010). https://doi.org/10.1038/jhh.2009.45
13. Odibo A.O., Zhong Y., Goetzinger K.R., et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta.2011.32(8).598-602. doi:10.1016/j.placenta.2011.05.006.
14. Akolekar, R., Syngelaki, A., Poon, L., Wright, D.,Nicolaides, K. H. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal diagnosis and therapy. 2013.33(1). 8-15. doi: 10.1159/000341264
15. O'Gorman, N., Wright, D., Poon, L. C. et al. Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation. Ultrasound in obstetrics & gynecology. 2017. 49(6). 751-755. doi: 10.1002/uog.17399
16. Chaemsaithong P., Sahota D.S., Poon L.C. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022.226(2S).S1071-S1097.e2. doi: 10.1016/j.ajog.2020.07.020
17. Nikol'skaya, I. G., Prokopenko, E. I., Vatazin, A. V., Budykina, T. S. Angiogenic and antiangiogenic factors in pregnant women with chronic kidney disease: the role of the sFlt-1/PlGF ratio in the prediction and diagnosis of preeclampsia. Nephrology and Dialysis. 2016.18(4). 440-451. In Russian
18. Bokulić A., Butorac D., Djaković I., Čukelj M., Rajković M.G. Investigating preeclampsia risk factors and angiogenic profiles in low-screening area. Acta Pharm. 2026.75(4).687-697. doi: 10.2478/acph-2025-0040.
19. Erez O., Romero R., Maymon E., et al. The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. PLoS ONE. 2017.12(7). e0181468. doi:10.1371/journal.pone.0181468
20. Sonek J, Krantz D, Carmichael J, et al. First trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Am J Obstet Gynecol .2018.218.126.e1–13. doi: 10.1016/j.ajog.2017.10.024
21. Crovetto F, Figueras F, Triunfo S, et al. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors. Prenat Diagn. 2015.35.183–91. doi: 10.1002/pd.4519
22. Gabidullina, R. I., Ganeeva, A. V., Shigabutdinova, T. N. Predictors of preeclampsia. Screening and prevention in the first trimester of pregnancy. Gynecology. 2021. 23(5). 428-434. doi: 10.26442/20795696.2021.5.201213. In Russian
23. Sidorova, I. S., Unanyan, A.L., Nikitina, N. A., MaKDonnell, V., Ageev, M. B. Current Possibilities for Predicting and Early Diagnosis of Preeclampsia. Russian Bulletin of Obstetricians and Gynecologists. 2021. 6,(21).32-43. doi:10.17116/rosakush20212106132. In Russian
Review
For citations:
Kurmanbaev T.E. MODERN POSSIBILITIES FOR PREDICTING PREECLAMPSIA. Transbaikalian Medical Bulletin. 2026;(2):132-138. (In Russ.) https://doi.org/10.52485/19986173_2026_2_132
Views:
27
JATS XML
Email this article 